✦ LIBER ✦

Discovery of Potent Vascular Endothelial Growth Factor Receptor-2 Inhibitors

✍ Scribed by Athanasios Papakyriakou; Maria E. Katsarou; Maria Belimezi; Michael Karpusas; Dionisios Vourloumis

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 802 KB
Volume: 5
Category: Article
ISSN: 1860-7179
DOI: 10.1002/cmdc.200900373

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Colorectal carcinoma cell production of

Colorectal carcinoma cell production of transforming growth factor beta decreases expression of endothelial cell vascular endothelial growth factor receptor 2

✍ Elizabeth A. Kuczynski; Alicia M. Viloria-Petit; Brenda L. Coomber 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

Vascular endothelial growth factor C and

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma

✍ Naoyo Nishida; Hirohisa Yano; Kan Komai; Takashi Nishida; Toshiharu Kamura; Masa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

## Abstract ## BACKGROUND The vascular endothelial growth factor (VEGF) family and VEGF receptors (VEGFR) play an essential role in the angiogenesis of both pathologic and nonpathologic conditions. However, the prognostic significance of VEGF and VEGFR expression in ovarian carcinoma is unclear.

Crystallization of the receptor binding

Crystallization of the receptor binding domain of vascular endothelial growth factor

✍ Christinger, Hans W.; Muller, Yves A.; Berleau, Lea T.; Keyt, Bruce A.; Cunningh 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

Vascular endothelial growth factor (VEGF) is a potent angiogenic factor with a unique specificity for vascular endothelial cells. In addition to its role in vasculogenesis and embryonic angiogenesis, VEGF is implicated in pathologic neovascularization associated with tumors and diabetic retinopathy.

Clinical significance of vascular endoth

Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma

✍ Hiroshi Kojima; Noriharu Shijubo; Gen Yamada; Shingo Ichimiya; Shosaku Abe; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Clinical significance of vascular endoth

Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma

✍ Mitsuyuki Arinaga; Tsuyoshi Noguchi; Shinsuke Takeno; Masao Chujo; Takashi Miura 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 1 views

## Abstract ## BACKGROUND Vascular endothelial growth factor C (VEGF‐C) plays an important role in lymphangiogenesis and activates VEGF receptor 3 (VEGFR‐3). By contrast, lymphatic spread is an important prognostic factor in patients with nonsmall cell lung carcinoma (NSCLC). The objective of the

Vascular endothelial growth factor C and

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck

✍ Csilla Neuchrist; Bohan M. Erovic; Allesandra Handisurya; Michael B. Fischer; Ge 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 1 views

## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (flt‐4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph